Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-06

Clinical Trial Update: Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation on Alleviating Major Depressive Disorder in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention:A Prospective, Double-Blind,Randomized Controlled Study [NA]

View source ↗

Summary

Prospective, double-blind, randomized trial assessing whether transcutaneous auricular vagus nerve stimulation can reduce depressive symptoms in patients with a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Transcutaneous Auricular Vagus Nerve Stimulation

Snippet

Sponsor: Jing Han | Conditions: Depressive Disorder (Per DSM-V Criteria, Mild-to-moderate), Acute Coronary Syndrome (ACS) | NA | Status: NOT_YET_RECRUITING